Authors : Dr. Vijay Kumar Dahiya; Dr. Ekta; Dr. Himanshu Goel

Volume/Issue : Volume 11 - 2026, Issue 6 - June

Google Scholar : https://tinyurl.com/yhkn5kwp

Scribd : https://tinyurl.com/ydr2mejt

DOI : https://doi.org/10.38124/ijisrt/26jun2027

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Background: Acute Lymphoblastic Leukemia (ALL) is the most common pediatric malignancy, accounting for nearly 25–30% of all childhood cancers. Early recognition of its clinical manifestationsis crucial for timely diagnosis, prompt initiation of therapy, and improved survival. Information regarding the clinical profile of childhood ALL from rural regions of Southern Haryana remains limited.  Objectives: To evaluate the demographic characteristics, clinical presentation, physical findings, and baseline hematological parameters of children diagnosed with Acute Lymphoblastic Leukemia at a tertiary care teaching hospital serving predominantly rural Southern Haryana.  Methods: A retrospective observational study was conducted in the Department of Pediatrics, NC Medical College & Hospital, Israna, Haryana. Medical records of children (0–18 years) diagnosed with ALL between January 2021 and December 2025 were reviewed.

Keywords : Acute Lymphoblastic Leukemia, Childhood Cancer, Clinical Presentation, Rural Haryana, Hematological Malignancy.

References :

1. Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):47-60. doi:10.1016/j.pcl.2014.09.004.
2. Naseem S, Varma N, Das R, Ahluwalia J, Sachdeva MU, Marwaha RK. Pediatric patients with bicytopenia/pancytopenia: review of etiologies and clinico-hematological profile at a tertiary center. Indian J Pathol Microbiol. 2011;54(1):75-80. doi:10.4103/0377-4929.77329.
3. Alim M, Verma N, Kumar A, Pooniya V, Abdul Rahman R. Etio-hematological profile and clinical correlates of outcome of pancytopenia in children: experience from a tertiary care center in North India. Cureus. 2021;13(6):e15382. doi:10.7759/cureus.15382.
4. Chatterjee T, Mahapatra M, Dixit A, Choudhry VP, Saxena R. Primary myelodysplastic syndrome in children: clinical, hematological and histomorphological profile from a tertiary care centre in India. Hematology. 2005;10(6):495-499. doi:10.1080/10245330500155556.
5. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371(9617):1030-1043. doi:10.1016/S0140-6736(08)60457-2.
6. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381(9881):1943-1955. doi:10.1016/S0140-6736(12)62187-4.
7. Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541-1552. doi:10.1056/NEJMra1400972.
8. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166-178. doi:10.1056/NEJMra052603.
9. Garg M, Abrol P, Gupta N, Bharti S, Nadda A. Analysis of clinical profile and role of various prognostic factors in early bone marrow response in children with acute lymphoblastic leukemia treated by Modified Multicenter Protocol (MCP) 841 protocol: experience from a tertiary care center in North India. Indian J Cancer. 2023;60(4):521-527. doi:10.4103/ijc.IJC_149_20.
10. Gogoi MP, Das P, Das N, et al. Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India. Lancet Reg Health Southeast Asia. 2025;37:100593. doi:10.1016/j.lansea.2025.100593.
11. Sarkar SD, Maiti D, Ghosh A, Ganguly M, Ahmed N. Immunophenotypic and cytogenetic characteristics of pediatric acute lymphoblastic leukemia: a burden estimation study from Eastern India. Indian J Public Health. 2024;68(1):21-25. doi:10.4103/ijph.ijph_889_23.
12. Pandita A, Harish R, Digra SK, Raina A, Sharma AA, Koul A. Molecular cytogenetics in childhood acute lymphoblastic leukemia: a hospital-based observational study. Clin Med Insights Oncol. 2015;9:39-42. doi:10.4137/CMO.S24463.
13. Acharya S, Maiti D, Datta S. Clinico-epidemiological study of extramedullary disease manifestations in childhood acute lymphoblastic leukaemia in a tertiary care centre. Int J Contemp Pediatr. 2018;5(4):1637-1640. doi:10.18203/2349-3291.ijcp20182580.
14. Siddaiahgari SR, Awaghad MA, Latha MS. Clinical, immunophenotype and cytogenetic profile of acute lymphoblastic leukemia in children at a tertiary health care centre in India. Muller J Med Sci Res. 2015;6(2):112-118. doi:10.4103/0975-9727.160676.
15. Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015;373(16):1541-1552. doi:10.1056/NEJMra1400972
16. Jaime-Pérez JC, García-Arellano G, Herrera-Garza JL, Marfil-Rivera LJ, Gómez-Almaguer D. Revisiting the complete blood count and clinical findings at diagnosis of childhood acute lymphoblastic leukemia: 10-year experience at a single center. Hematol Transfus Cell Ther. 2019;41(1):57-61. doi:10.1016/j.htct.2018.05.010
17. Clarke RT, Van den Bruel A, Bankhead C, Mitchell CD, Phillips B, Thompson MJ. Clinical presentation of childhood leukaemia: a systematic review and meta-analysis. Arch Dis Child. 2016;101(10):894-901. doi:10.1136/archdischild-2016-311251